PAG
XFOR icon

Private Advisor Group’s X4 Pharmaceuticals XFOR Stock Holding History

Private Advisor Group’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-617
Closed -$4.37K – 2585
2025
Q1 		$4.37K Hold
617
– – ﹤0.01% 2294
2024
Q4 		$13.6K Sell
617
-333
-35% -$5.31K ﹤0.01% 2249
2024
Q3 		$19.1K Buy
950
+100
+12% +$2.09K ﹤0.01% 2376
2024
Q2 		$14.8K Buy
850
+123
+17% +$4.02K ﹤0.01% 2306
2024
Q1 		$30.3K Hold
727
– – ﹤0.01% 2259
2023
Q4 		$18.3K Hold
727
– – ﹤0.01% 2195
2023
Q3 		$23.8K Buy
727
+67
+10% +$2.92K ﹤0.01% 2093
2023
Q2 		$38.4K Buy
+660
New +$33.9K ﹤0.01% 1978
2022
Q4 		– Sell
-441
Closed -$23K – 1983
2022
Q3 		$23K Hold
441
– – ﹤0.01% 1870
2022
Q2 		$13K Buy
+441
New +$16.8K ﹤0.01% 2087

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Private Advisor Group's XFOR Position: Q2 2025 in Review

Private Advisor Group sold out of X4 Pharmaceuticals (XFOR) in Q2 2025, closing a stake of 617 shares — an estimated $4.37K sold.

Private Advisor Group first reported a position in XFOR in Q2 2022 and held it in 10 quarters. The position peaked at $38.4K in Q2 2023. 51 funds tracked by Wall St. Rank hold XFOR as of Q2 2025.

  • Private Advisor Group reported no remaining X4 Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Private Advisor Group sold 617 X4 Pharmaceuticals shares in Q2 2025, an estimated $4.37K.
  • Private Advisor Group first reported a position in X4 Pharmaceuticals in Q2 2022 and held it in 10 quarters.
  • Private Advisor Group's X4 Pharmaceuticals position peaked at $38.4K in Q2 2023.
  • 51 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2025.

Based on Private Advisor Group's 13F filing for Q2 2025, filed 11 Aug 2025.